Xemed LLC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2004-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.xemed.com
Hyperpolarized Xenon Functional Lung Imaging in COPD Patients Undergoing Targeted Lung Denervation
Not yet recruiting
- Conditions
- COPD
- Interventions
- Diagnostic Test: Functional imaging of the lungs using MagniXene (hyperpolarized xenon-129) MRI
- First Posted Date
- 2023-04-18
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Xemed LLC
- Target Recruit Count
- 10
- Registration Number
- NCT05816616
Functional and Structural Assessment of Endobronchial Valve Recipients Using Dynamic Hyperpolarized Xenon-129 MRI
Phase 1
Recruiting
- Conditions
- COPD
- Interventions
- Drug: MagniXene Hyperpolarized Xenon MRI
- First Posted Date
- 2022-06-27
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Xemed LLC
- Target Recruit Count
- 100
- Registration Number
- NCT05433961
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI
Phase 1
Terminated
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- Combination Product: Hyperpolarized xenon MRI
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Xemed LLC
- Target Recruit Count
- 9
- Registration Number
- NCT05302817
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Assessment of Chronic Lung Allograft Dysfunction Using Single-breath & Multi-breath Hyperpolarized Xenon-129 MRI
Phase 1
Recruiting
- Conditions
- Lung Transplant Rejection
- Interventions
- Combination Product: Hyperpolarized 129-Xenon (MagniXene) MRI of the lung
- First Posted Date
- 2021-06-28
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Xemed LLC
- Target Recruit Count
- 90
- Registration Number
- NCT04941573
- Locations
- 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
129Xe MRI in Pediatric Population With BPD
Phase 1
Not yet recruiting
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Combination Product: MagniXene, hyperpolarized 129Xe MRI
- First Posted Date
- 2019-07-29
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Xemed LLC
- Target Recruit Count
- 30
- Registration Number
- NCT04035629
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI
Phase 2
Completed
- Conditions
- Asthma
- Interventions
- Drug: HXe MRI guided treatment sequence for BTOther: Standard treatment sequence for BT (control)
- First Posted Date
- 2013-04-16
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Xemed LLC
- Target Recruit Count
- 30
- Registration Number
- NCT01832363
- Locations
- 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
- First Posted Date
- 2013-04-16
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Xemed LLC
- Target Recruit Count
- 58
- Registration Number
- NCT01833390
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath